Thu.Feb 15, 2024

article thumbnail

Nitrogen?containing heterocyclic compounds: A ray of hope in depression?

Chemical Biology and Drug Design

Role of serotonin, dopamine, and norepinephrine in neural functions and symptoms involved during their altered levels. Abstract Depression is not similar to daily mood fluctuations and temporary emotional responses to day-to-day activities. Depression is not a passing problem; it is an ongoing problem. It deals with different episodes consisting of several symptoms that last for at least 2 weeks.

Research 189
article thumbnail

Can an antibody therapy prevent fentanyl overdoses?

Drug Discovery World

DDW Editor Reece Armstrong speaks to Tracy M Woody , President and Chief Executive Officer of Cessation Therapeutics, about the company’s goal to develop an antibody therapy to prevent fentanyl overdoses. Cessation Therapeutics is a pharmaceutical company that is developing antibody therapies to prevent and reverse overdosing caused by fentanyl. Recently, the company was awarded an additional grant from the National Institute on Drug Abuse (NIDA) to support the development of its anti- fentanyl

Therapies 148
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The brain is 'programmed' for learning from people we like

Science Daily: Pharmacology News

Our brains are 'programmed' to learn more from people we like -- and less from those we dislike. This has been shown by researchers in cognitive neuroscience in a series of experiments.

Research 140
article thumbnail

DDW webinar: Global opportunities in cell and gene therapy

Drug Discovery World

Hosted by DDW and sponsored by Astrea Biosciences “ Cell and gene therapies – how can market growth be sustained to maximise on opportunities ” – will be free to attend on 28 February at 7AM PST / 10AM EST / 3PM GMT / 4PM CET. Join this free webinar and learn about some of the key opportunities that are available to drug discovery and development companies following growth in the cell and gene therapy market.

Therapies 130
article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

Alnylam change to heart drug trial sparks doubts, sinking shares

BioPharma Drive: Drug Pricing

Analysts pressed Alnylam executives on the reasons for the changes to HELIOS-B, a Phase 3 study in ATTR amyloidosis with cardiomyopathy that is important to the company’s future.

article thumbnail

LNP formulations produce strong immune responses, data shows 

Drug Discovery World

The strengths of etherna’s lipid based nanoparticle (LNP) platform have been showcased in a peer-reviewed paper in Advanced Functional Materials. etherna’s Vice President, Technology & Innovation, Stefaan De Koker described the paper as a “landmark” for the company and its technology. The RNA technology company conducted the work in collaboration with the lab of Professor De Geest at Ghent University, and describes how delivery of mRNA encoded antigens in LNPs comprising a novel class

More Trending

article thumbnail

Webinar: Understand microbial control in biotherapy production

Drug Discovery World

Join DDW for this free event, Implementing rapid microbial identification in biotherapy manufacturing: Enhancing quality control and regulatory compliance , which is supported by Thermo Fisher Scientific. The event will take place on 26 February 3 pm GMT / 4 pm CET / 10 am EST / 7 am PST It will be presented by Phil Tuckett, BS, RM(NRCM, Department Scientist, Nelson Laboratories and Michelle Thai, Technical Sales Specialist, Pharma Analytics BioProduction Group, Thermo Fisher Scientific.

article thumbnail

Reforestation programs could threaten vast area of tropical grasslands

Science Daily: Pharmacology News

New research reveals the scale of inappropriate reforestation projects across Africa. A new study reveals that an area the size of France is threatened by forest restoration initiatives, such as the AFR100 initiative (African Forest Landscape Restoration Initiative), due to inappropriate restoration in the form of tree-planting.

Research 108
article thumbnail

$100M financing to advance immuno-dermatology pipeline 

Drug Discovery World

Alys Pharmaceuticals has launched with an R&D pipeline enabled by multiple platform technologies and a $100 million financing by Medicxi. The company originates from the aggregation of six Medicxi companies. Co-founded by Medicxi and several dermatology and scientific experts, including John Harris (UMass Chan Medical School), Brian Kim (Icahn School of Medicine at Mount Sinai), Lars French (LMU, Munich), Nobel Prize winner Craig Mello (UMass Chan Medical School), Eric Deutsch (Gustave Rou

article thumbnail

Evidence of geothermal activity within icy dwarf planets

Science Daily: Pharmacology News

A team found evidence for hydrothermal or metamorphic activity within the icy dwarf planets Eris and Makemake, located in the Kuiper Belt. Methane detected on their surfaces has the tell-tale signs of warm or even hot geochemistry in their rocky cores, which is markedly different than the signature of methane from a comet.

108
108
article thumbnail

Deliver Fast, Flexible Clinical Trial Insights with Spotfire

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

article thumbnail

Key to Tasty Tea May Be the Germs Found in Plants' Roots

Drugs.com

Good-tasting tea depends on soil microbes found in the plant’s roots, a new study says Microbes influence the production of theanine, an amino acid that contributes to tea flavor Synthetically produced microbial colonies boosted.

article thumbnail

Drug Excipient Business Development Reports now Available on Amazon

Drug Patent Watch

Elevate your excipient business strategies with the comprehensive Drug Excipient Business Development Reports from DrugPatentWatch. Designed for excipient manufacturers seeking lucrative opportunities in the pharmaceutical industry, these reports offer invaluable… The post Drug Excipient Business Development Reports now Available on Amazon appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 105
article thumbnail

Wrong RSV Shots Given to Some Pregnant Women, Young Kids

Drugs.com

THURSDAY, Feb. 15, 2024 -- More than two dozen toddlers and at least 128 pregnant women received RSV vaccines they should not have gotten, U.S. health officials say. The mixup, reported by the U.S.

Vaccine 105
article thumbnail

Ancient retroviruses played a key role in the evolution of vertebrate brains

Science Daily: Pharmacology News

Researchers report that ancient viruses may be to thank for myelin -- and, by extension, our large, complex brains. The team found that a retrovirus-derived genetic element or 'retrotransposon' is essential for myelin production in mammals, amphibians, and fish. The gene sequence, which they dubbed 'RetroMyelin,' is likely a result of ancient viral infection, and comparisons of RetroMyelin in mammals, amphibians, and fish suggest that retroviral infection and genome-invasion events occurred sepa

Virus 105
article thumbnail

Clinical Data Like You´ve Never Seen It Before: Why Spotfire Is the Leading Tool for Clinical Analytics

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

article thumbnail

Drug Used to Treat Rheumatoid Arthritis May Also Help Prevent It

Drugs.com

THURSDAY, Feb. 15, 2024 -- Philip Day loved playing soccer so much that the 35-year-old software engineer founded a website – FootballMatcher.com – to help people connect for pickup games.The fun went on pause when Day developed joint pain so.

article thumbnail

Diverse ancient volcanoes on Mars discovered by planetary scientist may hold clues to pre-plate tectonic activity on Earth

Science Daily: Pharmacology News

A geologist has revealed intriguing insights into the volcanic activity on Mars. He proposes that Mars has significantly more diverse volcanism than previously realized, driven by an early form of crust recycling called vertical tectonics. The findings shed light on the ancient crust of Mars and its potential implications for understanding early crustal recycling on both Mars and Earth.

92
article thumbnail

Hackensack meridian health biologist-turned-med student publishes COVID-19 vaccine study

SCIENMAG: Medicine & Health

First-year Hackensack Meridian School of Medicine (HMSOM) student Elizabeth Titova leveraged her background in phlebotomy and scientific research to publish a new clinical study around COVID-19 vaccination in Microbiology Spectrum, a peer-reviewed, open-access ASM Journal.

Vaccine 91
article thumbnail

AJPH Highlights Health Worker Mental Health

NIOSH Science Blog: Drugs

The American Journal of Public Health recently published a special supplement with 15 articles focusing on health worker mental health. This special issue of the journal was sponsored and edited by the National Institute for Occupational Safety and Health (NIOSH) and stems from the health worker mental health initiative from the Centers for Disease Control and Prevention and NIOSH.

Disease 88
article thumbnail

Clear and Accessible Writing

addgene Blog

Addgene was built on the concept of accessibility: making plasmids more accessible to scientists around the world. In 2004, that was a fairly simple goal… and we had no idea how much our understanding of what accessibility is would change over the next twenty years. But learn we did!

Science 86
article thumbnail

Discovery of new Li ion conductor unlocks new direction for sustainable batteries

Science Daily: Pharmacology News

Researchers have discovered a solid material that rapidly conducts lithium ions. Consisting of non-toxic earth-abundant elements, the new material has high enough Li ion conductivity to replace the liquid electrolytes in current Li ion battery technology, improving safety and energy capacity. The research team have synthesized the material in the laboratory, determined its structure and demonstrated it in a battery cell.

article thumbnail

Burnout: identifying people at risk

SCIENMAG: Medicine & Health

It is not uncommon for people to “hit the wall” at work and experience burnout for short or long periods of time. Credit: Photo: NTNU It is not uncommon for people to “hit the wall” at work and experience burnout for short or long periods of time.

77
article thumbnail

Root microbes may be the secret to a better tasting cup of tea

Science Daily: Pharmacology News

You'd think the complex flavor in a quality cup of tea would depend mainly on the tea varieties used to make it. But a new study shows that the making of a delicious cup of tea depends on another key ingredient: the collection of microbes found on tea roots. By altering that assemblage, the authors showed that they could make good-quality tea even better.

84
article thumbnail

Mount Sinai named official medical service provider for International Sumo League

SCIENMAG: Medicine & Health

For the first time, the Mount Sinai Health System has been named the official medical service provider for the International Sumo League—the world’s largest league of sumo wrestlers.

article thumbnail

“Ordinary Soil” Revisits the Weedkiller and AgBiotech Story, While Feeding the Scientist-As-Nerd Stereotype

PLOS: DNA Science

I love the spectacular symbiosis of my vegetable garden as harvest time approaches. Beanstalks spiral up cornstalks, their tendrils teasing nearby tomato stems. Below, broad leaves protect ballooning squashes from the slugs that appear, seemingly from nowhere, after a rain, while providing water for passing furry creatures. The synergism of a garden is an ancient and somewhat obvious idea.

Science 75
article thumbnail

Intellia, ReCode partner on genetic medicines for cystic fibrosis

BioPharma Drive: Drug Pricing

The partnership will use Intellia's "DNA writing” technology, and initially focus on people with the lung disease who have limited or no available treatment options.

DNA 73
article thumbnail

A star like a Matryoshka doll: New theory for gravastars

Science Daily: Pharmacology News

If gravitational condensate stars (or gravastars) actually existed, they would look similar to black holes to a distant observer. Two theoretical physicists have now found a new solution to Albert Einstein's theory of general relativity, according to which gravitational stars could be structured like a Russian matryoshka doll, with one gravastar located inside another.

80
article thumbnail

FDA Approves First Treatment for Severe Frostbite, Aurlumyn (iloprost)

Drugs.com

THURSDAY, Feb. 15, 2024 -- The U.S. Food and Drug Administration (FDA) on Wednesday approved the first treatment for severe frostbite. Known as Aurlumyn (iloprost), the injected medication lowers the risk of finger or toe amputation in cases of.

article thumbnail

Superbug killer: New synthetic molecule highly effective against drug-resistant bacteria

SCIENMAG: Medicine & Health

A new antibiotic created by Harvard researchers overcomes antimicrobial resistance mechanisms that have rendered many modern drugs ineffective and are driving a global public health crisis.

Drugs 72
article thumbnail

Versant-backed Firefly Bio wants to make the next generation of ADCs

BioPharma Drive: Drug Pricing

Armed with $94 million in funding, the biotech is marrying antibody-drug conjugates with protein degraders to create a new kind of cancer medicine.

Drugs 78
article thumbnail

Half of U.S. Health Care Workers Say They've Witnessed Racism Against Patients

Drugs.com

THURSDAY, Feb. 15, 2024 -- Nearly half of health care workers nationwide say they’ve seen discrimination against patients while on the job, a new report reveals.While 47% of health workers said they’ve witnessed discrimination against patients.

75
article thumbnail

Development of a Covalent Small Molecule Downmodulator for the Transcription Factor Brachyury

Covalent Modifiers

Davis H. Chase, Adrian M. Bebenek, Pengju Nie, Saul Jaime-Figueroa, Arseniy Butrin, Danielle A. Castro, John Hines, Brian M. Linhares, Craig M. Crews Angew. Chem. Int. Ed. 2024 , e202316496. [link] Brachyury is an oncogenic transcription factor whose overexpression drives chordoma growth. The downmodulation of brachyury in chordoma cells has demonstrated therapeutic potential, however, as a transcription factor it is classically deemed “undruggable”.

article thumbnail

New Treatment Brings Hope for Rare, Deadly Cancer Linked to Asbestos, Malignant Mesothelioma

Drugs.com

THURSDAY, Feb. 15, 2024 -- Mick worked in a factory boiler room in the 1970s, where he was exposed to asbestos. He didn’t think much of it until 2018, when he began to feel ill and dropped more than 40 pounds. The diagnosis: malignant.

article thumbnail

New patent for Calliditas drug TARPEYO

Drug Patent Watch

Annual Drug Patent Expirations for TARPEYO Tarpeyo is a drug marketed by Calliditas and is included in one NDA. It is available from one supplier. There is one patent protecting… The post New patent for Calliditas drug TARPEYO appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 59
article thumbnail

166 guidance documents the FDA is actively working on in 2024 (and beyond)

Agency IQ

BY CHELSEY MCINTYRE, PHARMD , ALEXANDER GAFFNEY, MS, RAC The FDA is set to be very, very busy in 2024. AgencyIQ has analyzed the agency’s guidance agendas, user fee commitment letters, statutory obligations and international efforts to determine which guidance documents the agency is actively working on this year (and in some cases, in the years ahead as well).

FDA 59